BioTime Raises $6.4 Million in Equity Financing

[Business Wire] – BioTime, Inc. , a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that on May 1, 2014, the Company received approximately $6.4 million in equity financing. more

View todays social media effects on BTX

View the latest stocks trending across Twitter. Click to view dashboard

See who BioTime is hiring next, click here to view